Assess the safety and effectiveness of the InnFocus MicroShunt when used to lower intraocular pressure (IOP) in subjects with primary open angle glaucoma where the IOP is not controlled when using maximum tolerated glaucoma medications.
This clinical trial is a prospective, randomized, controlled, multicenter, study. After informed consent is obtained, patients will be evaluated for eligibility based on glaucoma severity, eye health, and visual acuity. Clinical follow up will be scheduled over the course of the 24 month study, and examinations will be repeated to monitor eye health. At the 1 and 2 year follow up, diurnal (IOP taken in the morning, mid-day, and afternoon in the same day) IOP evaluation will be done. Annual follow up will occur up to 2 years. The primary effectiveness endpoint is 20% or greater reduction in IOP from pre-op medicated IOP at 12 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
732
An initial pocket is created under the conjunctiva and Tenon's capsule and the wound bed is treated for two minutes with mitomycin C (MMC, 0.2 mg/ml)soaked sponges. This is done using a "fornix-based" conjunctival incision at the corneoscleral junction. A partial thickness scleral flap with its base at the corneoscleral junction after cauterization of the flap area, and a window opening is created under the flap with a Kelly-punch to remove a portion of the sclera, Schlemm's canal and the trabecular meshwork to enter the anterior chamber. An iridectomy is done in many cases to prevent future blockage of the sclerostomy. The scleral flap is then sutured loosely back in place with several sutures. The conjunctiva is closed in a watertight fashion at the end of the procedure.
An initial pocket is created under the conjunctiva and Tenon's capsule and the wound bed is treated for two minutes with mitomycin C (MMC, 0.2 mg/ml)soaked sponges. This is done using a "fornix-based" conjunctival incision at the corneoscleral junction. After cauterization of the flap area, a knife is used to create a shallow pocket at the scleral surface and an opening into the AC. The device is then threaded through the track until the proximal end is in the anterior chamber and the fin of the device is pushed into the shallow scleral pocket. The device is checked to observe aqueous flow and the distal end placed under the Tenons/conjunctiva. The conjunctiva is closed in a watertight fashion at the end of the procedure.
Number of Participants With > 20% Decrease in Mean Diurnal Intraocular Pressure
The primary effectiveness outcome is ≥ 20% reduction in mean diurnal IOP without increasing number of glaucoma medications from baseline to 12 months follow-up
Time frame: 12 months
Number of Participants With > 20% Decrease in Diurnal Intraocular Pressure
The primary effectiveness outcome is ≥ 20% reduction in mean diurnal IOP without increasing number of glaucoma medications from baseline to 24 months follow-up
Time frame: 24 months
Mean Diurnal Intraocular Pressure Change
Secondary Effectiveness Endpoint #1 is the mean diurnal change in IOP from Screening at 12 months.
Time frame: 12 months
Mean Diurnal Intraocular Pressure Change
Secondary Effectiveness Endpoint #1 is the mean diurnal change in IOP from Screening at 24 months
Time frame: 24 months
Number of Participants With Postoperative Interventions at 12 Months
The Secondary Effectiveness Endpoint #2 was having any physical or medical postoperative intervention (other than eye massage) intended to alter IOP by the Month 12 follow-up visit.
Time frame: 12 months
Participants With Postoperative Interventions at 24 Months
The Secondary Effectiveness Endpoint #2 was having any physical or medical postoperative intervention (other than eye massage) intended to alter IOP by the Month 24 follow-up visit.
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Eye Physicians and Surgeons of Arizona
Glendale, Arizona, United States
Arizona Eye Consultants
Tucson, Arizona, United States
Vold Vision
Fayetteville, Arkansas, United States
University of California at Davis Eye Center
Davis, California, United States
UCLA Jules Stein Eye Institute
Los Angeles, California, United States
Ophthalmic Consultants of Connecticut
Fairfield, Connecticut, United States
Inter-Mountain Eye Care
Eagle, Idaho, United States
Chicago Glaucoma Consultants and CGC Eye Center
Glenview, Illinois, United States
Eugene and Marilyn Glick Eye Institute
Indianapolis, Indiana, United States
Stiles Eyecare Excellence
Overland Park, Kansas, United States
...and 19 more locations